02.01.2015 Views

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 4.2.2 continued<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study<br />

design<br />

Population<br />

characteristics<br />

Intervention<br />

Method<br />

Number indi<strong>vid</strong>uals<br />

Control<br />

Number<br />

indi<strong>vid</strong>uals<br />

Results<br />

Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Nelson<br />

2009<br />

[1]<br />

Systematic<br />

review<br />

All trials between 1980<br />

to december 2007 concerning<br />

the efficacy of<br />

antimicrobial prophylaxis<br />

for the prevention of postoperative<br />

wound infection<br />

in patients undergoing<br />

colorectal surgery. 182<br />

relevant trials were found<br />

through Medline, EmBase<br />

and Cochrane<br />

I1: Antibiotics prophylaxis<br />

(n=461)<br />

I2: Single-dose (n=757)<br />

I3: Aerobic cover + anaerobic<br />

cover (n=648)<br />

I4: Aerobic cover + anaerobic<br />

cover (n=1 184 included)<br />

I5: Combined non-absorbable<br />

oral + intravenous<br />

prophylaxis (n=1 176)<br />

I6: Combined non-absorbable<br />

oral + intravenous<br />

prophylaxis (n=143)<br />

I7: Antibiotic choice 28 trials<br />

C1: No antibiotics<br />

(n=352)<br />

C2: Multiple doses<br />

(n=1 784)<br />

C3: No aerobic<br />

cover (n=621)<br />

C4: No anaerobic<br />

cover (n=1 210)<br />

C5: Intravenous<br />

prophylaxis alone<br />

(n=1 186)<br />

C6: Oral nonabsorbable<br />

prophylaxis<br />

alone (n=140)<br />

C7: Gold standard<br />

(cefotetan,<br />

cefoxitin, doxycycline,<br />

oral<br />

neomycin/<br />

erythromycinbase).<br />

28 trials<br />

Surgical wound infection<br />

1. Favour antibiotic prophylaxis<br />

vs no antibiotics<br />

RR=0.30 (95% CI 0.22–0.41).<br />

2. Single dose vs multiple<br />

doses RR=1.06 (95% CI<br />

0.88–1.27)<br />

3. Favour additional aerobic<br />

cover RR=0.41 (95% CI<br />

0.23–0.71)<br />

4. Favour additional<br />

anaerobic cover RR=0.55<br />

(95% CI 0.35–0.85)<br />

5. Favour combined nonabsorbable<br />

oral and iv<br />

therapy vs iv therapy<br />

RR=0.55 (95% CI<br />

0.41–0.74)<br />

6. Favour combined<br />

non-absorbable oral and iv<br />

therapy vs non-absorbable<br />

oral therapy RR=0.34<br />

(95% CI 0.134–0.87)<br />

7. Different antibiotic<br />

vs gold standard<br />

RR=0 (95% CI 0.0–0.0)<br />

High<br />

Cochrane analysis<br />

with high quality.<br />

The quality of<br />

studies improved<br />

over the years.<br />

Studies in all<br />

language were<br />

considered<br />

(161 in english)<br />

The table continues on the next page<br />

172 antibiotikaprofylax <strong>vid</strong> <strong>kirurgiska</strong> <strong>ingrepp</strong> KAPITEL 4 • den systematiska litteraturöversikten<br />

173

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!